Lung Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
Cohort A
- People aged 50 to 80 years old at the time of joining the trial.
- Half of participants in this group are current smokers or people who quit within the last 15 years, with a smoking history of at least 20 pack-years (a measure of how much someone has smoked over their lifetime).
- The other half are people who have never smoked or smoked lightly (fewer than 20 pack-years, or who quit more than 15 years ago), and who have a parent, child, or sibling who has had lung cancer.
- People willing to have a low-dose chest scan (a type of imaging used for lung cancer screening).
- People willing to have a research blood draw taken during their screening scan visit, before any procedures or treatment related to a lung cancer diagnosis.
- People willing to be followed up for at least one year and at additional time points as set out in the study plan.
Cohort B
- People aged 50 to 80 years old at the time of joining the trial.
- Half of participants in this group are current smokers or people who quit within the last 15 years, with a smoking history of at least 20 pack-years.
- The other half are people who have never smoked or smoked lightly (fewer than 20 pack-years, or who quit more than 15 years ago), and who have a parent, child, or sibling who has had lung cancer.
- People who have already had a low-dose chest scan for lung cancer screening or diagnosis, where the scan found high-risk findings (classified as LUNG-RADS 4, a category indicating lesions that warrant further investigation).
- People willing to have a research blood draw taken before any further investigative procedures or treatment related to a lung cancer diagnosis.
- People willing to be followed up for at least one year and at additional time points as set out in the study plan.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have a serious health condition that is expected to significantly shorten their life or that would prevent them from being able to have lung surgery if needed.
- People who are having a certain type of detailed chest scan (contrast-enhanced CT) because they already have strong symptoms suggesting lung cancer.
- People who currently have lung cancer or have had it in the past.
- People who have had any other type of cancer in the past (though people who have had a certain type of skin cancer surgically removed at least 12 months before joining the study may still be considered — confirm with trial site).
- People who are currently taking medications used to treat cancer or to modify the course of rheumatic diseases.
- People who are currently being treated for pneumonia.
- People who have had a significant physical trauma, surgery, organ transplant, or blood transfusion within the 30 days before joining the trial.
- People with a known medical condition that the trial doctor believes would make participation unsuitable (confirm with trial site).
- People who have taken part in another clinical research study involving an experimental medicine or procedure within the 30 days before joining this trial, or where such treatment may continue into the screening period of this trial.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +84834105425
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The overall objective of this study is to assess the performance of SPOT-MAS LUNG (SML) in two different scenarios: lung cancer screening (Cohort A) and lung cancer diagnosis (Cohort B).
Can't join this trial?
Data last synced from ClinicalTrials.gov: 31 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.